Identification of the molecular site of ivabradine binding to HCN4 channels.
Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of i...
Guardado en:
Autores principales: | Annalisa Bucchi, Mirko Baruscotti, Marco Nardini, Andrea Barbuti, Stefano Micheloni, Martino Bolognesi, Dario DiFrancesco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6779caee5bf1410c9d6a58ff18238140 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An overview of ivabradine
por: Tumelo Ramoleta, et al.
Publicado: (2016) -
Electromechanical coupling mechanism for activation and inactivation of an HCN channel
por: Gucan Dai, et al.
Publicado: (2021) -
Gating mechanism of hyperpolarization-activated HCN pacemaker channels
por: Rosamary Ramentol, et al.
Publicado: (2020) -
HCN channels are not required for mechanotransduction in sensory hair cells of the mouse inner ear.
por: Geoffrey C Horwitz, et al.
Publicado: (2010) -
Ivabradine sensitive incessant atrial tachycardia
por: Satya Sudhish Nimmagadda, et al.
Publicado: (2021)